Russia's Sputnik vaccine applies for Phase 3 study in Brazil | WKZO | Everything Kalamazoo
Kalamazoo, MI, USA / WKZO | Everything Kalamazoo | 590 AM · 106.9 FM Dec 29, 2020 9:20 PM BRASILIA (Reuters) - Russias Sputnik V COVID-19 vaccine has requested regulatory approval to launch Phase 3 trials in Brazil, Brazilian health regulator Anvisa said late on Tuesday. The Sputnik vaccine is being developed by Moscows Gamaleya Research Institute and marketed by the Russian Direct Investment Fund (RDIF). Brazilian partner Uniao Quimica, a pharmaceutical company, entered the request with A...
Distrito Federal Leslie Adler Uniao Quimica Moscow Gamaleya Research Institute Russian Direct Investment Fund Gamaleya Research Institute
Source: wkzo.com